7 October 2020 in Disease Markers
Rolandic epilepsy is one of the most common epileptic syndromes in childhood. We used TMT-based proteomics and bioinformatics analysis to identify the differentially expressed proteins in plasma of children with Rolandic epilepsy. Our aim was to provide a molecular basis for exploring possible mechanisms underlying the pathogenesis of epilepsy. Subjects were divided into two groups (five in each): patients with Rolandic epilepsy as cases and patients with migraine as controls. Total proteins were extracted and quantitatively labeled with TMT, then analyzed using liquid chromatography mass spectrometry. Bioinformatics analysis was used to identify the hub genes. A total of 752 proteins were identified, of which 670 contained quantitative proteins. 217 differentially expressed proteins were identified, 46 of which were only upregulated in more than two groups and 111 of which were only downregulated in more than two groups. Bioinformatics analysis revealed top 10 hub genes in the up- and downregulated groups, respectively. Our study demonstrates that some differentially expressed proteins are associated with epilepsy. Activation of acute-phase or innate immune response and complement and fibrinogen systems and repression of glycolysis, lipoprotein metabolism, and antioxidant activity may play a role in the development of epilepsy.
1 September 2018 in Medicine
This study's purpose was to determine the sensitivity, false-positive and false-negative of seizure detection in adult intensive care by amplitude-integrated electroencephalography (aEEG) and color density spectral array (CDSA). 30 continuous electroencephalogram (EEG) recordings were randomly performed in 3 digital EEG-recording machines, 3 specialized neurophysiologists participated in this study, underwent 4 hours of training of CDSA and aEEG, marked any epochs suspected to be seizures without access to the raw EEG. The results will be compared and analyzed with continuous EEG reading to consider sensitivity, positive or negative rate. The recordings in this study, comprised 720 hours of EEG containing a total of 435 seizures. The median sensitivity for seizure identification was 80% of CDSA and 81.3% of aEEG, Median false-positive was 4 per 24 hours of CDSA, and 2 per 24 hours of aEEG display, Median false-negative was 4 per 24 hours of CDSA, and 4 per 24 hours of aEEG display. The time spent in identification of seizures by CDSA and aEEG was much time-saving than continuous EEG-reading. In this study, both CDSA and aEEG have a higher sensitivity but lower false-positive or missed rate in the interpretation of seizure identification in adult NICU.
22 April 2020 in Oncology Reports
An aberrant elongated tract of glutamine residues (polyQ) in proteins induces multiple diseases treated in the clinic. In our previous study of progressive myoclonic epilepsy (PME), using whole‑exome sequencing, a mutant Cav2.1 protein with an aberrant elongated polyQ tract was identified in PME patients. To investigate the molecular mechanism and cell biology of this aberrant elongated polyQ tract, wild‑type Cav2.1 with 13 polyQ repeats (Cav2.1 wt‑Q13) and mutant‑type Cav2.1 with 26 polyQ repeats (Cav2.1 mt‑Q26) were prepared and introduced into human SH‑SY5Y neuroblastoma cells. Using a WST‑1 assay, it was revealed that Cav2.1 mt‑Q26 markedly suppressed the proliferation of the SH‑SY5Y cells, a result not observed for the Cav2.1 wt‑Q13‑transfected cells. It was also revealed that Cav2.1 mt and its truncated molecules suppressed cell proliferation by inducing apoptosis rather than arresting the cell cycle. Further investigations indicated a nuclear translocation phenomenon associated with the Cav2.1 mt molecules. Mechanistically, it was revealed that the Cav2.1 mt molecules activated the Bcl‑2/Bax, caspase‑3 and poly ADP‑ribose polymerase (PARP) apoptotic pathways. The present study may provide new insights for interpreting the pathogenesis of PME and the relationship among polyQ, CACNA1A gene mutations and PME.